RESHAPE LIFESCIENCES INC (RSLS) Stock Balance Sheet
NASDAQ:RSLS - Nasdaq - US76090R3093 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 693.00K | 4.46M | 3.86M | 22.77M | 3.91M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.03M | 1.66M | 2.18M | 2.82M | 3.15M | |||
| Inventories | 2.46M | 3.74M | 3.61M | 3.00M | 0.00 | |||
| Other Current Assets | 407.00K | 437.00K | 260.00K | 1.36M | 780.00K | |||
| Total Current Assets | 4.59M | 10.30M | 9.91M | 29.94M | 7.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 154.00K | 310.00K | 870.00K | 1.72M | 1.48M | |||
| Intangibles | N/A | 0.00 | 260.00K | 20.83M | N/A | |||
| Other Non-Current Assets | 51.00K | 57.00K | 100.00K | 50.00K | 1.30M | |||
| Total Non-Current Assets | 205.00K | 367.00K | 1.23M | 22.59M | 2.78M | |||
| TOTAL ASSETS | 4.79M | 10.66M | 11.14M | 52.53M | 10.62M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 811.00K | N/A | N/A | 0.00 | N/A | |||
| Accrued Expenses | 1.01M | 1.17M | 4.09M | 2.59M | 4.43M | |||
| Accounts Payable | 2.21M | 1.69M | 1.93M | 3.47M | 620.00K | |||
| Other Current Liabilities | 957.00K | 921.00K | 1.46M | 1.48M | 0.00 | |||
| Total Current Liabilities | 4.99M | 3.78M | 7.48M | 7.53M | 5.05M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 430.00K | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 370.00K | N/A | |||
| Other Non-Current Liabilities | 61.00K | 223.00K | 0.00 | 300.00K | 480.00K | |||
| Total Non-Current Liabilities | 61.00K | 223.00K | 0.00 | 670.00K | 900.00K | |||
| TOTAL LIABILITIES | 5.05M | 4.00M | 7.48M | 8.20M | 5.95M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -642.70M | -635.57M | -624.19M | -577.97M | -184.76M | |||
| Additional Paid In Capital | 642.55M | 642.30M | 627.94M | 622.40M | 189.42M | |||
| Common Shares | 700.00 | 23.00K | 0.00 | 0.00 | 10.00K | |||
| Other Shareholders' Equity | -104.70K | -88.00K | -90.00K | -90.00K | N/A | |||
| Shares Outstanding | 730.00K | 404.40K | 520.00K | 360.00K | 50.00K | |||
| Tangible Book Value per Share | -0.35 | 16.48 | 6.54 | 65.28 | 93.40 | |||
| Total Shareholders' Equity | -253.00K | 6.66M | 3.66M | 44.33M | 4.67M | |||
| TOTAL LIABILITIES AND EQUITY | 4.79M | 10.66M | 11.14M | 52.53M | 10.62M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.09 | |||
| Current Ratio | 0.92 | 2.73 | 1.32 | 3.98 | 1.55 | |||
| Return On Assets (ROA) | -148.76% | -106.79% | -414.81% | -120.22% | -116.10% | |||
| Return On Equity (ROE) | N/A | -170.90% | -1262.57% | -142.45% | -264.03% | |||
All data in USD , ROIC based on taxRate of 0.21